These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 30460397)
1. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Pan C; Diplas BH; Chen X; Wu Y; Xiao X; Jiang L; Geng Y; Xu C; Sun Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Jiao Y; Yan H; Zhang L Acta Neuropathol; 2019 Feb; 137(2):297-306. PubMed ID: 30460397 [TBL] [Abstract][Full Text] [Related]
2. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas. Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443 [TBL] [Abstract][Full Text] [Related]
3. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018 [TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. Azad TD; Jin MC; Bernhardt LJ; Bettegowda C Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079 [TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid. Fujioka Y; Hata N; Akagi Y; Kuga D; Hatae R; Sangatsuda Y; Michiwaki Y; Amemiya T; Takigawa K; Funakoshi Y; Sako A; Iwaki T; Iihara K; Mizoguchi M J Neurooncol; 2021 Mar; 152(1):47-54. PubMed ID: 33417137 [TBL] [Abstract][Full Text] [Related]
6. Concordance analysis of cerebrospinal fluid with the tumor tissue for integrated diagnosis in gliomas based on next-generation sequencing. Wang Q; Liang Q; Wei W; Niu W; Liang C; Wang X; Wang X; Pan H Pathol Oncol Res; 2023; 29():1611391. PubMed ID: 37822669 [No Abstract] [Full Text] [Related]
7. Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients. Guo W; Jin L; Liang J; Lin G; Zheng J; Zhou D; Zhan S; Sun H; Jiang X Clin Chim Acta; 2022 Sep; 534():81-92. PubMed ID: 35810802 [TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples. Ma C; Yang X; Xing W; Yu H; Si T; Guo Z Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608 [TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine. Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma. Fontanilles M; Deniel A; Marguet F; Beaussire L; Magne N; Derrey S; Blanchard F; Alexandru C; Coutant S; Laquerrière A; Clatot F; Di Fiore F; Sarafan-Vasseur N Rev Neurol (Paris); 2022 Nov; 178(9):975-980. PubMed ID: 35871016 [TBL] [Abstract][Full Text] [Related]
11. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Martínez-Ricarte F; Mayor R; Martínez-Sáez E; Rubio-Pérez C; Pineda E; Cordero E; Cicuéndez M; Poca MA; López-Bigas N; Ramon Y Cajal S; Vieito M; Carles J; Tabernero J; Vivancos A; Gallego S; Graus F; Sahuquillo J; Seoane J Clin Cancer Res; 2018 Jun; 24(12):2812-2819. PubMed ID: 29615461 [No Abstract] [Full Text] [Related]
12. Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC. Wu J; Liu Z; Huang T; Wang Y; Song MM; Song T; Long G; Zhang X; Li X; Zhang L Mol Oncol; 2023 May; 17(5):810-824. PubMed ID: 36495130 [TBL] [Abstract][Full Text] [Related]
13. Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors. Ronsley R; Karvonen KA; Cole B; Paulson V; Stevens J; Crotty EE; Hauptman J; Lee A; Stasi SM; Lockwood CM; Leary SES J Neurooncol; 2024 Jun; 168(2):215-224. PubMed ID: 38755519 [TBL] [Abstract][Full Text] [Related]
14. Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease. Ballester LY; Glitza Oliva IC; Douse DY; Chen MM; Lan C; Haydu LE; Huse JT; Roy-Chowdhuri S; Luthra R; Wistuba II; Davies MA J Neuropathol Exp Neurol; 2018 Jul; 77(7):628-635. PubMed ID: 29873738 [TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor DNA in Adults With Glioma: A Systematic Review and Meta-Analysis of Biomarker Performance. McMahon JT; Studer M; Ulrich B; Revuelta Barbero JM; Pradilla I; Palacios-Ariza MA; Pradilla G Neurosurgery; 2022 Aug; 91(2):231-238. PubMed ID: 35535984 [TBL] [Abstract][Full Text] [Related]
16. Assessment of ctDNA in CSF may be a more rapid means of assessing surgical outcomes than plasma ctDNA in glioblastoma. Li JH; He ZQ; Lin FH; Chen ZH; Yang SY; Duan H; Jiang XB; Al-Nahari F; Zhang XH; Wang JH; Zhang GH; Zhang ZF; Li C; Mou YG Mol Cell Probes; 2019 Aug; 46():101411. PubMed ID: 31173881 [TBL] [Abstract][Full Text] [Related]
17. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Panditharatna E; Kilburn LB; Aboian MS; Kambhampati M; Gordish-Dressman H; Magge SN; Gupta N; Myseros JS; Hwang EI; Kline C; Crawford JR; Warren KE; Cha S; Liang WS; Berens ME; Packer RJ; Resnick AC; Prados M; Mueller S; Nazarian J Clin Cancer Res; 2018 Dec; 24(23):5850-5859. PubMed ID: 30322880 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis. Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745 [TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing. Iwahashi N; Sakai K; Noguchi T; Yahata T; Matsukawa H; Toujima S; Nishio K; Ino K Sci Rep; 2019 Jul; 9(1):10426. PubMed ID: 31320709 [TBL] [Abstract][Full Text] [Related]
20. Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma. Duan H; Hu JL; Chen ZH; Li JH; He ZQ; Wang ZN; Zhang GH; Guo XY; Liang L; Mou YG Chin Med J (Engl); 2020 Jun; 133(12):1415-1421. PubMed ID: 32558704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]